当前位置:首页 » 新闻资讯 » 行业动态

波士胶收购CGM地面处理系统业务

来源: 编辑: 人气:1753 时间:2017-09-07

  雅本化学5月16日晚间公告,公司与 AMINO CHEMICALS LIMITED(以下简称“ACL 公司”) 股东意大利蒂法马梵思股份有限公司(以下简称“蒂法马梵思”)共同签署了《股权购买协议》,拟通过自有资金或自筹资金等方式以 24,458,000 欧元购买ACL公司 100%股权。

公司称,ACL公司是拥有 FDA 认证的国际优良的 API 制造和 CMO 服务供应商,拥有近二十年S仿药(First-to-File)申请经验,具有向世界顶消泡剂级跨国药企提供产品和服务的能力。目前,国产特色原料药品种较少,国外医药市场注册经验不足,cGMP生产体系和发达国家相比有一定差距,使得国内制药企业和国外大型药企合作的余地较小,而通过收购 ACL 公司可以弥补上述不足。此外,ACL 公司将与蒂法马梵思签订五年协议,在本次交易交割完成后 36 个月内,ACL 公司将作为蒂法马梵思 CMO 业务的 供应商。同时,雅本化学将与 ACL 公司原股东公司蒂法马梵思形成战略合作,公司将每年为蒂法马梵思股份有限公司提供医药中间体产品。

Jabil Chemical plans to acquire 100% stake in ACL

Jabil Chemical announced on the evening of May 16 that the Company and AMINO CHEMICALS LIMITED (hereinafter referred to as "ACL Company"), the shareholder of Italy Timafana Vatican Co., Ltd. (hereinafter referred to as "Tifafan Vatican & rdquo; ) Jointly signed the Equity Purchase Agreement, which intends to purchase 100% equity of ACL Company for EUR 24,458,000 by self-owned funds or self-raised funds.

According to the company, ACL is an FDA-certified leading international API manufacturing and CMO service provider with nearly two decades of First-to-File application experience, Pharmaceutical companies to provide products and services capacity. At present, there are fewer domestically-made specialty APIs and the lack of registered experience in foreign pharmaceutical markets. There is a certain gap between the cGMP production system and the developed countries, which makes it very difficult for domestic pharmaceutical companies to cooperate with large pharmaceutical companies abroad. However, by acquiring ACL companies, Make up the above deficiencies. In addition, ACL will sign a five-year agreement with Tifama Vatican, which will be the sole provider of Timahfance's CMO business within 36 months of completion of the transaction. At the same time, Jabil Chemical will form strategic cooperation with Tifafman Fethiye, the former shareholder of ACL Company. The company will provide pharmaceutical intermediates products to Tifpharma Fethiye Co., Ltd. every year.

TAG:
凯茵化工公众号

【版权声明】秉承互联网开放、包容的精神,凯茵化工欢迎各方(自)媒体、机构转载、引用我们原创内容,但要注明来源凯茵化工;同时,我们倡导尊重与保护知识产权,如发现本站文章存在版权问题,请将版权疑问、授权证明、版权证明、联系方式等,发邮件至 app@shkingchem.com,我们将第一时间核实、处理,感谢您的配合。

【版权声明】秉承互联网开放、包容的精神,凯茵化工欢迎各方(自)媒体、机构转载、引用我们原创内容,但要注明来源凯茵化工;同时,我们倡导尊重与保护知识产权,如发现本站文章存在版权问题,请将版权疑问、授权证明、版权证明、联系方式等,发邮件至 app@shkingchem.com,我们将第一时间核实、处理,感谢您的配合。

点击/扫码填问卷